Regulation of IRF and STAT gene expression by retinoic acid

Leukemia and Lymphoma

Volumn 30, Issue 1-2, 1998, Pages 63-71

  Matikainen, Sampsa ^a   Lehtonen, Anne ^a   Sareneva, Timo ^a   Julkunen, Ilkka ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Interferons; IRF; Promyelocytic leukemia; Retinoic acid; STAT

Indexed keywords

ALPHA INTERFERON; ANTIMITOTIC AGENT; INTERFERON; REGULATOR PROTEIN; RETINOIC ACID; STAT1 PROTEIN; STAT2 PROTEIN; TRANSCRIPTION FACTOR;

CANCER INHIBITION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN HL 60; GENE EXPRESSION REGULATION; HUMAN; MYELOID LEUKEMIA; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0031843124     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809050930     Document Type: Review

References (54)

1. Lotan, R. (1996). Retinoids in cancer chemoprevention. FASEB J., 10, 1031-1039.
2. Borden, E. C. (1992). Interferons-expanding therapeutic roles. N. Engl. J. Med., 326, 1491-1493.
3. Cirelli, R. and Tyring, S. (1995). Major therapeutic uses of interferons. Clin. Immunother., 3, 27-87.
4. Eisenhauer, E. A., Lippman, S. M., Cavanagh, J. J., Parades-Espinoza, M., Arnold, A., Hong, W. K., Massimini, G., Schleuniger, U., Bollag, W., Holdener, E. E. and Krakoff, I. (1993). Combination of 13-cis-retinoic acid and interferon α-2a in therapy of solid tumors. Leukemia, 8, 1622-1625.
5. Chambon, P. (1996). A decade of molecular biology of retinoic acid receptors. FASEB J., 10, 940-954.
6. de The, H. (1996). Altered retinoic acid receptors. FASEB J., 10, 955-960.
7. Chomienne, C., Fenaux, P. and Degos, L. (1996). Retinoid differentiation therapy in promyelocytic leukemia. FASEB J., 10, 1025-1030.
8. Grignani, F., Ferrucci, P. F., Testa, U., Talamo, G., Fagioli, M., Alcalay, M., Mencarelli, A., Grignani, F., Peschle, C., Nicoletti, I. and Pelicci, P. G. (1993). The acute promyelocytic-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell, 74, 423-431.
9. Rousselot, P., Hardas, B., Patel, A., Guidez, F., Gäken, J., Castaigne, S., Dejean, A., de The, H., Degos, L., Farzaneh, F. and Chomienne, C. (1994). The PML-RARα gene product of the t(15,17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells. Oncogene, 9, 545-551.
10. Lanotte, M., Martin-Thouvenin, V., Najman, S., Balerini, P., Valensi, F. and Berger, R. (1991). NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood, 77, 1080-1086.
11. Huang, M., Ye, Y. C., Chen, B. R., Chai, J. R., Lu, J. X., Zhoa, L., Gu, L. J., Wang, Z. Y. (1988). Use of all-trans-retinoic acid in the treatment of acute promyelocytic leukemia. Blood, 72, 567-572.
12. Castaigne, S., Chomienne, C., Daniel, M. T., Ballerini, P., Berger, R., Fenaux, P. and Degos, L. (1990). All-trans-retinoic acid as a differentiation theraphy for acute promyelocytic leukemia. I. Clinical results. Blood, 76, 1704-1709.
13. Warrell, R. P., Frankel, S. R., Miller, W. H., Scheinberg, D. A., Itri, L. M., Hittelman, M. N., Vyas, R., Andreeff, M., Tafuri, A., Jakubowski, A., Gabrilove, J. and Gordon, M. S. (1991). Differentiation therapy for acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N. Engl. J. Med., 324, 1385-1393.
14. Harada, H., Fujita, T., Miyamoto, M., Kimura, Y., Maruyama, M., Furia, A., Miyata, T. and Taniguchi, T. (1989). Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN inducible genes. Cell, 58, 729-739.
15. Pine, R., Decker, T., Kessler, D. S., Levy, D. E. and Darnell, J. E., Jr. (1990). Purification and cloning of interferon-stimulated gene factor 2 (ISGF2): 1SGF2 (IRF-1) can bind to the promoters of both beta-interferon and interferon-stimulated genes but is not a primary transcriptional activator of either. Mol. Cell. Biol., 10, 2448-2457.
16. Maruyama, M., Fujita, T. and T. Taniguchi (1989). Sequence of a cDNA coding for human IRF-1. Nucleic Acids Res., 17, 3292.
17. Itoh, S., Harada, H., Fujita, T., Mimura, T. and Taniguchi, T. (1989). Sequence of a cDNA coding for human IRF-2. Nucleic Acids Res., 17, 8372.
18. Au, W-C., Moore, P. A., Lowther, W., Juang, Y-T. and Pitha, P. M. (1995). Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes. Proc. Natl. Acad. Sci., 92, 11657-11661.
19. Yamagata, T., Nishida, J., Tanaka, T., Sakai, R., Mitani, K., Yoshida, M., Taniguchi, T., Yazaki, Y. and Hirai, H. (1996). A novel interferon regulatory factor family transcription factor, ICSAT/Pip/LSIRF, that negatively regulates the activity of interferon-regulated genes. Mol. Cell. Biol., 16, 1283-1294.
20. Veals, S. A., Schindler, C., Leonard, D., Fu, X-Y., Aebersold, R., Darnell, J. E., Jr. and Levy, D. E. (1992). Subunit of an alpha-interferon-responsive transcription factor is related to interferon regulatory factor and myb families of DNA-binding proteins. Mol. Cell. Biol., 12, 3315-3324.
21. Weiz, A., Marx, P., Sharf, R., Appella, E., Driggers, P. H., Ozato, K. and Levi, B-Z. (1992). Human interferon consensus sequence binding protein is a negative regulator of enhancer elements common to interferon-inducible genes. J. Biol. Chem., 267, 25589-25596.
22. Driggers, P. H., Elenbaas, B. A., An, J.-B., Lee, I. J. and Ozato, K. (1992). Two upstream elements activate transcription of major histocompability complex class I gene in vitro. Nucleic Acids Res., 20, 2533-2540.
23. Matsuyama, T., Grossman, A., Mittrucker, H. W., Siderovski, D. P., Kiefer, F., Kawakami, T., Richardson, C. D., Taniguchi, T., Yoshinaga, S. K. and Mak, T. W. (1995). Molecular cloning of LSIRF, a lymphoid-specific member of the inteferon regulatory factor family that binds the interferon-stimulated response element (ISRE). Nucleic Acids Res., 23, 2127-2136.
24. Eisenbeis, C. F., Singh, H. and Storb, U. (1995). Pip, a novel IRF family member, is a lymphoid-specific, PU. 1-dependent transcriptional activator. Genes Dev., 9, 1377-1387.
25. Mittrucker, H-W., Matsuyama, T., Grossman, A., Kundig, T. M., Potter, J., Shahinian, A., Wakeham, A., Patterson, B., Ohashi, P. S. and Mak, T. W. (1997). Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science, 275, 540-543.
26. Bluyssen, H. A. R., Durbin, J. E. and Levy, D. E. (1996). ISGF3γp48, a specificity switch for interferon activated transcription factors. Cytokine and Growth Factor Reviews, 7, 11-17.
27. Tanaka, N., Kawakami, T. and Taniguchi, T. (1993). Recognition DNA sequences of inteferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol. Cell. Biol., 13, 4531-4538.
28. Kimura, T., Kadokawa, Y., Harada, H., Matsumoto, M., Sato, M., Kashiwazaki, Y., Tarutani, M., Sok-Pin Tan, R., Takasugi, T., Matsuyama, T., Mak, T. W., Noguchi, S. and Taniguchi, T. (1996). Essential and non-redundant roles of p48 (ISGF3y) and IRF-1 in both type I and type II inteferon responses, as revealed by gene targeting studies. Genes to Cells, 1, 115-124.
29. Bovolenta, C., Driggers, P. H., Marks, M. S., Medin, J. A., Poltis, A. D., Vogel, S. N., Levy, D. E., Sakaguchi, K., Appella, E., Coligan, J. E. and Ozato, K. (1994). Molecular interactions between interferon consensus sequence binding protein and members of the interferon regulatory factor family. Proc. Natl. Acad. Sci., 91, 5046-5050.
30. Sharf, R., Meraro, D., Azriel, A., Thornton, A. M., Ozato, K., Petricoin, E. F., Schaper, F., Hauser, H. and Levi, B. Z. (1997). Phosphorylation events modulate the ability of interferon consensus sequence binding protein to interact with interferon regulatory factors and to bind DNA. J. Biol. Chem., 272, 9785-9792.
31. Taniguchi, T., Harada, H. and Lamphier, M. (1995). Regulation of the interferon system and cell growth by the IRF transcription factors. J. Cancer Res. Clin. Oncol., 121, 516-520.
32. Harada, H., Kitagawa, M., Tanaka, N., Yamamoto, H., Harada, K., Ishihara, M. and Taniguchi, T. (1993). Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science, 259, 971-974.
33. Tanaka, N., Ishihara, M., Kitagawa, M., Harada, H., Kimura, T., Matsuyama, T., Lamphier, M. S., Aizawa, S., Mak, T. W. and Taniguchi, T. (1993). Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell, 77, 829-839.
34. Tamura, T., Ishihara, M., Lamphier, M. S., Tanaka, N., Oishi, I., Aizawa, S., Matsuyama, T., Mak, T. W., Taki, S. and Taniguchi, T. (1995). An IRF-1 dependent pathway of DNA-damage induced apoptosis in mitogen activated T-lymphocytes. Nature, 376, 596-599.
35. Willman, C. L., Sever, C. E., Pallavicini, M. G., Harada, H., Tanaka, N., Slovak, M. L., Yamamoto. H., Harada, K., Meeker, T. C., List, A. F. and Taniguchi, T. (1993). Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science, 259, 968-971.
36. Holtschke, T., Löhler, J., Kanno, Y., Fehr, T., Giese, N., Rosenbauer, F., Lou, J., Knobeloch, K-P., Gabriele, L., Waring, J. F., Bachmann, M. F., Zinkernagel, R. M., Morse H. C., III, Ozato, K. and Horak, I. (1996). Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell, 87, 307-317.
37. Matikainen, S., Ronni, T., Hurme, M., Pine, R. and Julkunen, I. (1996). Retinoic acid activates interferon regulatory factor-1 gene expression in myeloid cells. Blood, 88, 114-123.
38. Gianni, M., Terao, M., Fortino, I., LiCalzi, M., Viggiano, V., Barbui, T., Rambaldi, A. and Garattini, E. (1997). Stat1 is induced and activated by all-trans retinoic acid in acute promyelocytic leukemia cells. Blood, 89, 1001-1012.
39. Giandomenico, V., Lancillotti, F., Fioruggi, G., Percario, Z. A., Rivabene, R., Malorni, W., Affabris, E. and Romeo, G. (1997). Retinoic acid and IFN inhibition of cell proliferation is associated with apoptosis in squamous carcinoma cell lines: role of IRF-1 and TGase II-dependent pathways. Cell Growth & Differ., 8, 91-100.
40. Sims, S. H., Cha, Y., Romine, M. F., Gao, P.-Q., Gottlieb, K. and Deisseroth, A. (1993). A novel interferon-inducible domain: structural and functional analysis of the human interferon regulatory factor 1 gene promoter. Mol. Cell. Biol., 13, 690-702.
41. Pine, R., Canova, A. and Schindler, C. (1994). Tyrosine phosphorylated p91 binds to a single element in the ISGF2/IRF-1 promoter to mediate induction by IFNα and IFGγ, and is likely to autoregulate the p91 gene. EMBO J., 13, 158-167.
42. Lehtonen, A., Matikainen, S. and Julkunen, I. (1997). Interferons upregulate STAT1, STAT2, and IRF family transcription factor gene expression in human peripheral blood mononuclear cells and macrophages. J. Immunol., 14, 794-803.
43. Ohmori, Y., Schreiber, R. D. and Hamilton, T. A. (1997). Synergy between interferon-gamma and tumor necrosis factor-alpha in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor kappaB. J. Biol. Chem., 272, 14899-14907.
44. Matikainen, S., Ronni, T., Lehtonen, A., Sareneva, T., Melen, K., Nordlin, S., Levy, D. E. and Julkunen, I. (1997). Retinoic acid induces signal transducers and activator of transcription (STAT) 1, STAT2, and p48 expression in myeloid leukemia cells and enhances their responsiveness to interferons. Cell Growth & Differ., 8, 687-698.
45. Kolla, V., Lindner, D. J., Weihua, X., Borden, E. C. and Kalvakolanu, D. J. (1996). Modulation of interferon (IFN)-inducible gene expression by retinoic acid. J. Biol. Chem., 271, 10508-10514.
46. Xu, B., Grander, D., Sangfelt, O. and Einhorn, S. (1994). Primary leukemia cells resistant to α-interferon in vitro are defective in the activation of the DNA-binding factor interferon-stimulated gene factor 3. Blood, 84, 1942-1949.
47. Watanabe, N., Sakakibara, J., Hovanessian, A. G., Taniguchi, T. and Fujita, T. (1991). Activation of IFN-β element by IRF-1 requires a posttranslational event in addition to IRF-1 synthesis. Nucleic Acids Res., 19, 4421-4428.
48. Nagata, S. (1997). Apoptosis by death factor. Cell, 88, 355-365.
49. Tanaka, N., Ishihara, M., Lamphier, M. S., Nozawa, H., Matsuyama, T., Mak, T. W., Aizawa, S., Tokino, T., Oren, M. and Taniguchi, T. (1996). Cooperation of the tumor suppressors IRF-1 and p53 in response to DNA damage. Nature, 382, 816-818.
50. Kamijo, R., Harada, H., Matsuyama, T., Bosland, M., Gerecitano, J., Shapiro, D., Le, J., Koh, S. J., Kimura, T., Green, S. J., Mak, T. W., Taniguchi, T. and Vilcek, J. (1994). Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science, 263, 1612-1615.
51. Kamijo, R., Harada, H., Matsuyama, T., Bosland, M., Gerecitano, J., Shapiro, D., Le, J., Koh, S. J., Kimura, T., Green, S. J., Mak, T. W., Taniguchi, T. and Vilcek, J. (1994). Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science, 263, 1612-1615.
52. Moilanen, E. and Vapaatalo, H. (1995). Nitric oxide in inflammation and immune response. Ann. Med., 27, 359-367.
53. Albina, J. E., Abate, J. A. and Henry, W. L. (1991). Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T-cell proliferation: a role of IFN-gamma in the induction of nitric oxide synthesizing pathway. J. Immunol., 147, 1441-1448.
54. Mills, C. D. (1991). Molecular basis of "suppressor" macrophages: arginine metabolism via the nitric oxide synthase pathway. J. Immunol., 146, 2719-2723.